Parental Assessment of Pain Control Following Pediatric Circumcision: Do Opioids Make a Difference? - 11/08/21
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
Abstract |
Objective |
To determine whether a postoperative prescription for opioids affects parental assessment of pain control following pediatric circumcision.
Methods |
This postoperative survey assessed the parental assessment of pain control in 199 patients, ages<18 years undergoing circumcision. This study was conducted at a quaternary care children's hospital in Houston, Texas from December 2018 to January 2020. Postoperative pain regimens included acetaminophen and ibuprofen or combination hydrocodone/acetaminophen in addition to ibuprofen for postoperative analgesia based on the surgical preference. The primary study outcome was identification of the proportion of parents rating their child's analgesia following pediatric circumcision as poor or inadequate based on the postoperative analgesic regimen.
Results |
Of the 502 surveys sent, the response rate was 40% (199/502) of those who received the survey email, and 64% (199/308) for those who opened the email. Between the opioid and nonopioid groups, there was no difference in, race/ethnicity (Caucasian; 28% vs 37%; P = .43) or insurance status (insured; 51% vs 45%; P = .44). The proportion of parents who rated their child's pain as poor or inadequately controlled following circumcision was relatively rare:5.5% and 1.1% in the nonopioid and opioid groups, respectively. Parents rating their child's pain as excellent with regards to pain control following circumcision were 61% and 53% in the nonopioids and opioid groups, respectively.
Conclusion |
The results of this study indicate that nonopioid analgesic regimens following pediatric circumcision were not associated with decreased parental satisfaction or an increasing assessment of poor or inadequately controlled pain. Limiting opioid exposure following pediatric circumcision is feasible and does not result in worse parental satisfaction with the analgesic plan.
Le texte complet de cet article est disponible en PDF.Plan
Financial Disclosures: Dr. Austin is a consultant to Allergan and Urovant. The remainder of the authors have no potential, perceived or real conflicts of interest. |
|
Funding Support: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. |
|
A portion of the manuscript was presented in abstract form at the American Academy of Pediatrics Meeting, October 2019, New Orleans LA. |
Vol 154
P. 263-267 - août 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?